Abstract
Febuxostat Immediate Release Tablet were prepared by direct compression method using varying concentrations of Lycoat, Crospovidone & Croscarmellose sodium as disintegrants. The formulations prepared were evaluated for Precompression& post compression parameters. Form the drug excipient compatibility studies we observe that there are no interactions between the pure drug (Febuxostat) and optimized formulation (Febuxostat + excipients) which indicates there are no physical changes. Post compression parameters was found to be within the limits. Among the formulation prepared the tablet containing 12mg of CCS shows 98.45% of the drug release within 40 min & follows first order kinetics.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: UPI Journal of Pharmaceutical, Medical and Health Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
